The present invention relates to new AGC kinase inhibitors, in particular to compounds of Formula (I) or (II) or a stereoisomer, tautomer, racemic, metabolite, pro- or predrug, salt, hydrate, or solvate thereof, wherein Ar
1
, Ar
2
, R
1
, R
3
, p and n have the meaning defined in the claims. In particular, the present invention relates to more specifically ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease.
本发明涉及新的AGC激酶
抑制剂,特别是公式(I)或(II)或其立体异构体,互变异构体,外消旋体,代谢物,前药或前药,盐,
水合物或溶剂化物的化合物,其中Ar1,Ar2,R1,R3,p和n具有权利要求中定义的含义。特别地,本发明涉及更具体的ROCK
抑制剂,包括这种
抑制剂的制剂,特别是药物制剂,并且涉及这种
抑制剂在治疗和预防疾病中的用途。